[PC1] Corporate Exhibition

Corporate ExhibitionVaccine Science

[PC1-01] Advanced technologies for mRNA-based therapeutics
- saRNA and HARNA^TM, new mRNA optimizing -

*Ken Miyajima¹, Akiko Yanagiya¹, Rena Akahori², Tomohiro Sawadaishi¹, Aoi Onuma¹, Yanwen Feng¹, Satoshi Abe¹, Jun Nihira¹, Tetsuo Yoshida¹, Kazuyuki Nakashima¹ (1. ARCALIS, Inc. (Japan), 2. Hitachi, Ltd., Research development group (Japan))

Password required to view

Log in

or